Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-Chemical Inhibitors & Agonists-Cell Cycle/DNA Damage-Cyclin-dependent Kinase (CDK)-RGB-286638
RGB-286638

Chemical Structure : RGB-286638

CAS No.: 784210-87-3

RGB-286638 (RGB286638)

Catalog No.: PC-21089Not For Human Use, Lab Use Only.

RGB-286638 is a small-molecule multi-targeted cyclin-dependent kinase (CDK) inhibitor with IC50 of 1-5 nM for cyclin T1-CDK9, cyclin B1-CDK1, cyclin E-CDK2, cyclin D1-CDK4, cyclin E-CDK3, and p35-CDK5.

Packing Price Stock Quantity
5 mg $98 In stock
10 mg $148 In stock
25 mg $258 In stock
50 mg $428 In stock
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

RGB-286638 is a small-molecule multi-targeted cyclin-dependent kinase (CDK) inhibitor with IC50 of 1-5 nM for cyclin T1-CDK9, cyclin B1-CDK1, cyclin E-CDK2, cyclin D1-CDK4, cyclin E-CDK3, and p35-CDK5.
RGB-286638 is less potent against cyclin H-CDK7 and cyclin D3-CDK6.
RGB-286638 also inhibits several tyrosine and serine/threonine non-CDK enzymes with IC50 of 1-50 nM, i.e. GSK-3β, TAK1, AMPK, Jak2, MEK1.
RGB-286638 potently inhibits cell growth of human p53-wt (MM.1S, MM.1R, and H929) and p53-mutant (U266, OPM1, and RPMI) MM cells with EC50 of 20-70 nM.
RGB-286638 (50nM) reduces the phosphorylation of Rb at S807/811 in MM.1S and MM.1R cells, but has no effects on p-Rb S780.
RGB-286638 induces cytotoxicity in p53 knockdown MM.1S, exhibits anti-MM activity in vivo.

Physicochemical Properties

M.Wt 618.56
Formula C29H37Cl2N7O4
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

N-[1,4-Dihydro-3-[4-[[4-(2-methoxyethyl)-1-piperazinyl]methyl]phenyl]-4-oxoindeno[1,2-c]pyrazol-5-yl]-N′-4-morpholinylurea hydrochloride (1:2)

References

1. Cirstea D, et al. Leukemia. 2013 Dec;27(12):2366-75.

2. van der Biessen DA, et al. Clin Cancer Res. 2014 Sep 15;20(18):4776-83.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: